The new Fiscal Code brings additional challenges for the pharmaceutical industry in Romania

The new Fiscal Code brings major changes, including changes for the pharmaceutical market. The way in which big players on the market will be able to manage the advantages and disadvantages brought by the new fiscal legislation will have a significant impact on their financial performance.

“The business environment must deal with the major fiscal challenges with which it is confronted. A new Fiscal Code is about to be published and only the tax payers who are ready for these changes will be able to benefit from the advantages offered by it and, at the same time, diminish the potential negative consequences”, says Miruna Enache, Partner within the Fiscal Assistance department at EY Romania.


For more information, please see the Romanian version of the article, here.